The largest database of trusted experimental protocols

Macs separation

Manufactured by Miltenyi Biotec
Sourced in Germany, United Kingdom, United States

MACS separation is a magnetic cell separation technology developed by Miltenyi Biotec. It allows for the isolation and enrichment of target cells from complex biological samples. The core function of MACS separation is to provide a versatile and efficient method for separating and purifying specific cell populations based on their surface marker expression.

Automatically generated - may contain errors

49 protocols using macs separation

1

Murine Hematopoietic Stem Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM cells from donor B6 mice (allo-HSCT) or BDF mice (syn-HSCT) were flushed out of the tibia and femur. The solution was carefully passed through a 23 G needle and over a 70 µm cell strainer (BD Biosciences, San Jose, CA, USA) and a single-cell suspension was prepared in phosphate-buffered saline (PBS)/2% fetal calf serum/1mM EDTA. Lineage depletion was obtained by Magnetic Activated Cell Sorting (MACS) separation (Miltenyi Biotec, Bergisch Gladbach, Germany), using CD5, CD45R (B220), CD11b, GR-1 (Ly-6G/C), 7-4, Ter-119 as lineage markers, and a following fluorescently activated cell sort (FACS) by marker expression Sca-1+ and c-Kit+.
+ Open protocol
+ Expand
2

Isolation of Human Monocytes from Blood Leukocyte Cones

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human blood from anonymous healthy donors was obtained in the form of leukocyte cones from the NHS Blood and Transplant service. Leukocyte cones contain waste leukocytes isolated from individuals donating platelets via apharesis, and consist of a small volume (~10 ml) of packed leukocytes with few red blood cells or platelets. For monocyte isolation, blood was diluted with 1:3 with PBS followed by separation using ficoll gradient centrifugation as previously described (White et al., 2014 (link)). Following human peripheral blood mononuclear cell (PBMC) isolation and washing, a total of 1.25 × 108 PBMCs were labelled and positively selected with CD14 micro-beads and MACS separation (Miltenyi Biotec, Bisley, Surrey, UK). Monocytes were resuspended at 4 × 106 cells/ml in chemotaxis buffer (RPMI 1640/25 mM HEPES/0.5% (w/v) BSA) and left on ice until required.
+ Open protocol
+ Expand
3

Isolation and Stimulation of CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve BALB/c mice were sacrificed and CD4+ T cells were isolated from the LNs by magnetic-activated cell sorting (MACS) separation (Miltenyi Biotec, Bergisch Gladbach, Germany).
Jurkat cells were stimulated with phorbol myristate acetate (PMA)/calcium ionophore A23187 for 24 h. The supernatants were collected, and IL-2 mRNA levels were determined.
+ Open protocol
+ Expand
4

Isolation and Differentiation of Murine Th17 and Th1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The spleens were extracted from Balb/c mice and naive CD4+ T cells were purified by using a magnetic cell sorting system (MACS® separation, Miltenyi Biotech, Bergisch Gladbach, Germany). The cells were cultured in RPMI 1640 culture media with 10% heat-inactivated FBS (Cellgro, Herndon, VA, USA), 100 U/mL penicillin (Cellgro), 0.1 mg/mL streptomycin (Cellgro), 2 mM L-glutamine (Cellgro), and 0.05 μM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, USA) at 37°C in a 5% CO2-humidified incubator. Plate-bound anti-CD3 antibody (1 μg/mL, ebioscience) and anti-CD28 antibody (1 μg/mL, ebioscience) were used to stimulate T cells. Recombinant mouse IL-6 (25 ng/mL, BD, San Jose, CA, USA) and TGF-β (2.5 ng/mL, BD) were used for Th17 differentiation, and IL-2 (10 ng/mL, BD), IL-12 (5 ng/mL, Biosource, Camerillo, CA, USA), and anti-IL-4 (5 μg/mL) were added to induce differentiation into Th1 cells.
+ Open protocol
+ Expand
5

Maintenance and purification of P. falciparum cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
P. falciparum 3D7 parasites were maintained in continuous culture in RPMI-HEPES medium supplemented with hypoxanthine (370 μM), gentamicin (30 μg/ml), 25 mM sodium bicarbonate and 0.25% AlbuMAX II (GIBCO) or 5% heat-inactivated human sera in O+ RBCs from malaria-naive donors (Australian Red Cross blood bank).30 (link) Cultures were incubated at 37°C in 1% O2, 5% CO2, 94% N2 and used for antibody assays. Schizont stage parasites were purified by MACS separation (Miltenyl Biotec), followed by incubation with the protease inhibitor E64 (10 μg/ml) to prevent rupture of the infected erythrocyte membrane. Upon complete development, segmented merozoites were isolated by filtration (1.2 μm), counted by flow cytometry and coated onto ELISA plates for antibody measurements.
Magnet purified infected RBCs (iRBCs) were stored at 1:2 in Glycerolyte 57 Solution (Baxter Healthcare Corporation) for in vitro stimulation assays.
+ Open protocol
+ Expand
6

Isolation and Culture of Murine Myoblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiment protocols were approved by Institutional Animal Care and the Use Committee of University of Minnesota. Satellite cell-derived primary myoblasts such as CD31(−), CD45(−), Sca-1(−), and integrin α7(+) cells were isolated from skeletal muscles of 2 month-old mice (C57BL6, Charles River Laboratories, Wilmington, MA, USA) by MACS separation (Miltenyi Biotec, San Diego, CA, USA) as described previously (3 ). Myoblasts were maintained on collagen-coated dishes in growth medium (GM) (Ham’s/F10 [Sigma-Aldrich, St., Louis, MO, USA], 20% FBS, 20 ng/ml basic FGF [R&D Systems, Minneapolis, MN, USA] and 1% Penicillin/Streptomycin [Invitrogen, Carlsbad, CA, USA]) (7 (link)). Proliferating myoblasts in GM were defined as day 0. Then myogenic differentiation was caused by replacing GM with differentiation medium (DM) (DMEM [Sigma-Aldrich], 5% horse serum and 1% Penicillin/Streptomycin) for 3 days.
+ Open protocol
+ Expand
7

Isolation and Characterization of Human Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human blood was obtained from healthy donors with informed consent and ethical approval in the form of leukocyte cones purchased from the NHS Blood and Transplant service. Leukocyte cones contain waste leukocytes isolated from individuals donating platelets via apheresis and consist of a small volume (~10 ml) of packed leukocytes with few red blood cells or platelets. For monocyte isolation, blood was diluted with 1:2 with PBS followed by separation using a Histopaque gradient and centrifugation as previously described (Purvis et al., 2020 (link)). Following human peripheral blood mononuclear cell (PBMC) isolation and washing, approximately 1 × 108 PBMCs were labelled and negatively selected using the pan human monocytes isolation kit and MACS separation (Miltenyi Biotec, Bisley, Surrey, UK), typically yielding around 5 × 106 monocytes defined as CD11b+CD114+CD16. Monocytes were resuspended at 4 × 106 cells·ml−1 in chemotaxis buffer (RPMI 1640, 25‐mM HEPES, 0.5% [w/v] BSA) and left on ice until required.
+ Open protocol
+ Expand
8

Isolation of Human Blood-Derived AC133+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood was mixed with Dulbecco's phosphate-buffered saline (DPBS) at a ratio of 1:1, and the mixed sample was then layered on to Ficoll-paque PLUS (GE Healthcare, Sweden) to isolate mononuclear cells (MNCs). After centrifugation, the MNC layer was collected, transferred to tubes, and washed using 2 mM EDTA/PBS. To deplete red blood cells, an RBC lysis solution (Qiagen) was added, followed by gentle mixing and incubation at RT for 10 minutes. To isolate human peripheral blood-derived AC133+ cells with high purity (more than 99%), isolated MNCs were incubated with FcR-blocking reagents and CD133 microbeads, and MACS separation (Miltenyi Biotec) was carried out. Isolated cells were washed with 2% fetal bovine serum (FBS; Gibco) containing MACS buffer.
+ Open protocol
+ Expand
9

Isolation of Murine T Cells and Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female C57BL/6 and IFNγR−/− mice were obtained from Jackson Labs (Bar Harbor, ME) and were housed in the Rockefeller University specific pathogen free animal facility. CXCL10−/− mice were obtained from the laboratory of Dr. A. Luster at Massachusetts General Hospital. All animal procedures were performed according to IACUC-approved animal protocols. Mice were immunized intraperitoneally with influenza A/PR/8 (Charles River Laboratory, Wilmington, MA) two weeks before spleens were harvested for isolation of CD4+ and CD8+ T cells by MACS separation (Miltenyi Biotec, Auburn, CA). Dendritic cells (DC) were generated from bone marrow cells grown in RPMI/10%FBS with GM-CSF from J558L cell culture supernatant.14 (link) Elispot plates (Millipore, Billerica, MA) were coated with and detection performed with anti- IFNγ antibody matched pair (MabTech, Mariemont, OH). Spots were counted in a blinded fashion by Zellnet Consulting (Fort Lee, NJ).
+ Open protocol
+ Expand
10

Isolation and Analysis of Hepatic Myeloid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver mononuclear cells were obtained as previously described (13 (link)). Mouse cell samples were stained using antibodies from BD Biosciences and eBioscience (available upon request). When indicated, tumor-induced hepatic myeloid cells were isolated using CD11b beads followed by MACS separation (Miltenyi Biotec, USA). Purity after enrichment was above 90%. Flow cytometry was performed on BD FACS Calibur or LSRII using CellQuest Pro or FACS Diva acquisition software respectively (Becton Dickinson, USA). Data were analyzed using FlowJo software (Tree Star, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!